NCT05475379View on ClinicalTrials.gov

Non-inferiority Trial of Locally Manufactured Typhoid Conjugate Vaccine 'Typhocon' in Bangladesh

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

630

Participants

Timeline

Start Date

July 1, 2022

Primary Completion Date

June 30, 2023

Study Completion Date

July 31, 2023

Conditions
Typhoid
Interventions
BIOLOGICAL

Typhoid Vi polysaccharide-diphtheria toxoid conjugate vaccine (Vi-DT)

"Typhoid Vi-polysaccharide-diphtheria toxoid conjugate vaccine (Vi-DT) Typhocon will be manufactured by Incepta Vaccine Limited"

Trial Locations (1)

1212

International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka

All Listed Sponsors
lead

International Centre for Diarrhoeal Disease Research, Bangladesh

OTHER